Status:
COMPLETED
Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy
Lead Sponsor:
Gillette Children's Specialty Healthcare
Conditions:
Cerebral Palsy
Femoral Derotation Osteotomy
Eligibility:
All Genders
25+ years
Brief Summary
Excessive anteversion is commonly observed in the cerebral palsy (CP) population. This can be treated by an orthopedic surgery, called femoral derotation osteotomy (FDO), to de-rotate the femur. It is...
Detailed Description
Excessive anteversion is commonly observed in the CP population. If individuals do not internally rotate their femurs as a compensation for this bony torsion, excessive anteversion decreases the coron...
Eligibility Criteria
Inclusion
- Diagnosed with bilateral CP (i.e., hemiplegics excluded)
- Minimum age of 25 years presently
- Had a preoperative gait analysis
- Underwent only 1 external, proximal FDO per side
- Minimum 5 years since an FDO
- FDO implants have been removed
- No prior pelvic osteotomy
- Able to speak and read English
- Not pregnant
- Control group (-FDO):
- Same as cases, except no FDO
- Matched to cases at baseline (using a matching algorithm)
Exclusion
- none
Key Trial Info
Start Date :
September 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2019
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT03444116
Start Date
September 12 2017
End Date
November 15 2019
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota, United States, 55101